← Leaderboards
Ronald P Hart
Rutgers, The State Univ Of N.J.
$3,152,001
Attributed
$8,953,058
Total exposure
8
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2009–25$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,953,058 · 8
By mechanism
R01$3,678,769 · 1
RF1$2,209,242 · 1
R21$2,068,632 · 5
RC1$996,415 · 1
Top collaborators
- Zhiping P. Pang9 shared
- Jennifer Gladys Mulle4 shared
- Carlos N Pato4 shared
- Arnold B. Rabson2 shared
- Jay Arnold Tischfield2 shared
- Jeffrey D Zahn2 shared
- Manolis Kellis1 shared
Most similar at Rutgers, The State Univ Of N.J.
Same institution · by research overlap
- Jeffrey D Zahn$545,354
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsNeuronsAffectTechnologyPhenotypeInduced Pluripotent Stem CellGene ExpressionGenesGenetic VariantCell LineCell TypeMolecularSynapsesGenotypeStem Cell BiologyVariantMutationImageCell PhysiologyProtocols DocumentationGenomicsPathway InteractionsPharmaceutical PreparationsComplex
Grant awards (16)
Cellular consequences and convergent biology of schizophrenia-associated rare variants in the GPC cohort$2,209,242
RF1 · FY2025 · MH
Cellular consequences and convergent biology of schizophrenia-associated rare variants in the diverse GPC cohort$1,144,561
R01 · FY2024 · MH
Cellular consequences and convergent biology of schizophrenia-associated rare variants in the diverse GPC cohort$1,255,460
R01 · FY2023 · MH
Cellular consequences and convergent biology of schizophrenia-associated rare variants in the diverse GPC cohort$1,278,748
R01 · FY2022 · MH
Modeling HIV-associated neurocognitive disorders and encephalopathy in human iPSC brain organoids containing microglia$235,500
R21 · FY2021 · NS
Modeling HIV-associated neurocognitive disorders and encephalopathy in human iPSC brain organoids containing microglia$195,000
R21 · FY2020 · NS
High throughput multicompartment culture chambers to develop neurocircuit models of addiction risk$190,328
R21 · FY2016 · DA · contact PI
High throughput multicompartment culture chambers to develop neurocircuit models of addiction risk$191,622
R21 · FY2015 · DA · contact PI
Developing an In Vitro Neurocircuitry Model of Addiction using Risk-Associated Hu$197,352
R21 · FY2014 · DA
Developing an In Vitro Neurocircuitry Model of Addiction using Risk-Associated Hu$187,177
R21 · FY2013 · DA
Developing an In Vitro Neurocircuitry Model of Addiction using Risk-Associated Hu$24,637
R21 · FY2013 · DA
Phenotypic analysis of human iPSC carrying addiction-associated gene variants$193,750
R21 · FY2012 · DA
Phenotypic analysis of human iPSC carrying addiction-associated gene variants$231,000
R21 · FY2011 · DA
Genome-wide chromatin modification targeting by endogenous small RNAs$996,415
RC1 · FY2010 · CA · contact PI
Epigenetic regulation of microRNAs in neurogenesis$191,779
R21 · FY2010 · MH · contact PI
Epigenetic regulation of microRNAs in neurogenesis$230,487
R21 · FY2009 · MH · contact PI